+852-3069 6950
sales@gugent.com.hk
Catalog No. CYT40017018
Part No. 40017018
Supplier Cytiva
Acrodisc syringe filters - Sterile with Versapor membrane
Net Price
972
Availability

4 weeks

PROPERTIES
  • Effective Filtration Area
    2.8 cm²
  • Membrane material
    Versapor acrylic copolymer on a nonwoven support
  • Sterile
    Sterile
  • Pore Size
    0.8 µm
  • Seals
    2.8 cm²
DESCRIPTION
Acrodisc™ syringe filters with Versapor™ membrane, a Pall Life Sciences product, are the economical choice for clarification or prefiltration of virtually all aqueous samples. Certified non-pyrogenic and biologically safe Available in a variety of diameters and pore sizes Specifications Materials of Construction Filter Media: Versapor™ membrane (acrylic copolymer on a non-woven support) 50 mm Prefilter Media: Binder-free borosilicate glass fiber 4, 13, and 50 mm (PN 4572) Housing: Polypropylene 25 mm and 50 mm (PN 4276) Housing: Modified acrylic Effective Filtration Area 4 mm: 0.3 cm2 13 mm: 1.0 cm2 25 mm: 2.8 cm2 50 mm: 19.6 cm2 Inlet/Outlet Connections 4, 13, and 25 mm: Female luer-lok inlet, male slip luer outlet 50 mm: 10.4 - 12.7 (1/4 - 1/2 in.) stepped hose barbTypical Hold-up Volume(with air purge) 4 mm: 13 mm: 25 mm: 50 mm: Maximum Operating Temperature 4, 13, and 25 mm: 55°C (131°F) 50 mm: 82°C (180°F) Maximum Operating Pressure 4, 13, and 25 mm: 5.2 bar (520 kPa, 75 psi) 50 mm: 4.1 bar (410 kPa, 60 psi) Typical Water Flow Rate mL/min at 3.1 bar (310 kPa, 45 psi) 0.45 µm, 4 mm: 3 0.8 µm, 13 mm: 180 0.45 µm, 25 mm: 225 0.8 µm, 25 mm: 600 1.2 µm, 25 mm: 660 5 µm, 25 mm: 970 mL/min at 1.0 bar (100 kPa, 15 psi) 5 µm, 50 mm: 1700 Endotoxin Level Biological Safety Passes United States Pharmacopeia (USP) Biological Reactivity Test, In Vivo Sterilization PN 4188, 4190, 4199, 4276 sterilized by gamma irradiation and individually blister packaged. Applications Useful for prefiltration of particulate-laden samples, serum filtration, and dissolution testing. Protects instrumentation against particulate build up.
CUSTOMERS ALSO VIEWED